Kus, F.; Sirvan, F.; Yildirim, H.C.; Koc, I.; Guduk, N.; Arik, Z.
Prognostic Impact of Pre-Treatment Modified Glasgow Prognostic Score (mGPS) on Survival in Patients with Advanced-Stage Ovarian Cancer. J. Clin. Med. 2025, 14, 4239.
https://doi.org/10.3390/jcm14124239
AMA Style
Kus F, Sirvan F, Yildirim HC, Koc I, Guduk N, Arik Z.
Prognostic Impact of Pre-Treatment Modified Glasgow Prognostic Score (mGPS) on Survival in Patients with Advanced-Stage Ovarian Cancer. Journal of Clinical Medicine. 2025; 14(12):4239.
https://doi.org/10.3390/jcm14124239
Chicago/Turabian Style
Kus, Fatih, Firat Sirvan, Hasan Cagri Yildirim, Ilgin Koc, Naciye Guduk, and Zafer Arik.
2025. "Prognostic Impact of Pre-Treatment Modified Glasgow Prognostic Score (mGPS) on Survival in Patients with Advanced-Stage Ovarian Cancer" Journal of Clinical Medicine 14, no. 12: 4239.
https://doi.org/10.3390/jcm14124239
APA Style
Kus, F., Sirvan, F., Yildirim, H. C., Koc, I., Guduk, N., & Arik, Z.
(2025). Prognostic Impact of Pre-Treatment Modified Glasgow Prognostic Score (mGPS) on Survival in Patients with Advanced-Stage Ovarian Cancer. Journal of Clinical Medicine, 14(12), 4239.
https://doi.org/10.3390/jcm14124239
